Galectin 8/Gal-8 Antibody

Skip to product information
1 of 2

Selleck Chemicals

SKU:F2772-20UL

Regular price €149,00 EUR
Regular price Sale price €149,00 EUR
Sale Sold out
Shipping calculated at checkout.
Size
Quantity
View full details

About the Target

LGALS8 is a target of interest in many antibody-based workflows. Galectin 8/Gal-8 is a tandem-repeat-type β-galactoside-binding lectin widely expressed in human tissues and involved in diverse physiological and pathological processes. It contains two distinct carbohydrate recognition domains (N-CRD and C-CRD) connected by a linker peptide of variable length (33 aa in Gal-8S, 75 aa in Gal-8L), with the N-CRD uniquely showing high affinity for α2-3-sialylated or 3′-sulfated β-galactosides, and the C-CRD preferentially binding branched N-glycans. Depending on the literature source, LGALS8 may also be discussed as Galectin 8/Gal-8 and Galectin-8.

Reported cellular context includes cytoplasm and cytoplasmic vesicle, which can matter when signal is compared across treatments or changing cell states. Following LGALS8 across matched perturbations can help separate abundance effects from shifts in localization, complex assembly, or pathway state.

Research Context

LGALS8 is commonly interpreted in the context of cancer and immunology research, and readouts are often stronger when a study separates expression changes from compartment-level redistribution. When reported signal spans cytoplasm and cytoplasmic vesicle, a defined reference condition can make comparisons more interpretable across perturbations, passages, or replicate sets.

Consider these angles when interpreting target-level changes:

  • apparent redistribution between cytoplasm and cytoplasmic vesicle across matched conditions
  • changes associated with proliferative state, oncogenic signaling, or treatment response
  • context differences tied to immune-cell state, activation, or lineage composition
  • co-patterning with orthogonal markers and control conditions that clarify pathway state

Variant Considerations

If your project spans exploratory questions, the regular version offers a balanced option for establishing baseline signal behavior for LGALS8. This can help when protocols evolve over time and the goal is to compare experiments using a stable reference workflow.

Standardize sampling time, control choice, and downstream analysis thresholds so apparent differences in LGALS8 reflect biology rather than handling. When interpreting LGALS8, it is often useful to decide early whether the main question is overall abundance, compartmental enrichment, or context-dependent redistribution.

For multi-run studies, a shared reference condition can keep LGALS8 trends easier to compare across datasets. That kind of consistency is especially helpful when follow-up work expands to new perturbations, model systems, or longitudinal collections.

Targets:
LGALS8
Research Area:
Cancer • Immunology
Application:
FCM • IF • IHC • IP • WB
Reactivity:
Human
Specificity:
Galectin 8/Gal-8 Antibody [G6M19] detects endogenous levels of total Galectin 8/Gal-8 protein.
Host:
Rabbit
Clonality:
Monoclonal
Clone:
G6M19
UniProt:
O00214
Storage Buffer:
PBS, pH 7.2+50% Glycerol+0.05% BSA+0.01% NaN₃
Storage Temperature:
-20°C

For Research Use Only. Not intended for diagnostic or therapeutic use.
Products may be subject to intellectual property rights.

The purchase of this product does not grant any license for commercial use, manufacturing, or clinical applications. The user is responsible for ensuring compliance with applicable laws and third-party rights.